Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Chung

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Journal of Viral Hepatitis|August 14, 2009
Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysisK E Corey, J Mendez-Navarro, E C Gorospe, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2011
The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirinA A Butt, T Umbleja, J W Andersen, et al.
HIV Medicine|June 15, 2007
Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study TeamF T Aweeka, M Kang, J-Y Yu, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2017
Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVESD K Li, P Yan, A-B Abou-Samra, et al.
Journal of Viral Hepatitis|May 26, 2010
HCV synergizes with body weight in the promotion of insulin resistanceA Delgado-Borrego, Y Kamegaya, S H Jordan, et al.
Journal of Viral Hepatitis|August 14, 2009
Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C populationM Rodriguez-Torres, M S Sulkowski, R T Chung, et al.
Transplantation|October 3, 1999
Viruses and thrombotic microangiopathyS Baid, M Pascual, A B Cosimi, et al.
Journal of Viral Hepatitis|October 10, 2012
Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 studyN Kemmer, L Hua, J W Andersen, et al.
Journal of Viral Hepatitis|February 26, 2018
Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVESJ Y Chen, Y Ren, P Yan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 17, 2000
Prevalence of hepatitis C virus-associated mixed cryoglobulinemia after liver transplantationG A Abrahamian, A B Cosimi, M L Farrell, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of Viral Hepatitis|August 14, 2009
Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysisK E Corey, J Mendez-Navarro, E C Gorospe, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2011
The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirinA A Butt, T Umbleja, J W Andersen, et al.
HIV Medicine|June 15, 2007
Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study TeamF T Aweeka, M Kang, J-Y Yu, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2017
Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVESD K Li, P Yan, A-B Abou-Samra, et al.
Journal of Viral Hepatitis|May 26, 2010
HCV synergizes with body weight in the promotion of insulin resistanceA Delgado-Borrego, Y Kamegaya, S H Jordan, et al.
Journal of Viral Hepatitis|August 14, 2009
Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C populationM Rodriguez-Torres, M S Sulkowski, R T Chung, et al.
Transplantation|October 3, 1999
Viruses and thrombotic microangiopathyS Baid, M Pascual, A B Cosimi, et al.
Journal of Viral Hepatitis|October 10, 2012
Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 studyN Kemmer, L Hua, J W Andersen, et al.
Journal of Viral Hepatitis|February 26, 2018
Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVESJ Y Chen, Y Ren, P Yan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 17, 2000
Prevalence of hepatitis C virus-associated mixed cryoglobulinemia after liver transplantationG A Abrahamian, A B Cosimi, M L Farrell, et al.
Pageof 6